Back to Results
First PageMeta Content
Food and Drug Administration / Clinical research / Pharmaceutical industry / Piperazines / Clinical trial / New Drug Application / Norfloxacin / Pharmaceutical sciences / Pharmacology / Research


GlaxoWe//come September 25, [removed] “$X3SW28 l\9:53
Add to Reading List

Document Date: 1998-10-28 11:17:05

Open Document

File Size: 340,58 KB

Share Result on Facebook

Company

Glaxo Wellcomc Inc. / Glaxo Wellcome Inc. / /

Event

FDA Phase / /

IndustryTerm

prescription drug products / research-based pharmaceutical / /

Organization

Congress / FDAMA Conference Committee / Food and Drug Administration / Reviewing Division / Division of Glaxo Wellcomc Inc. Docket Number 98D-0265 / /

/

Position

Director an Office / Director of an Office / applicable Oflice Director / Director sign-off / Ofllce Director / Director / Regulato~ Affairs / Ph.D. Group / /

Product

New Drug / /

ProvinceOrState

Maryland / /

Technology

drug development / /

SocialTag